Erivedge: payments to doctors
Payments that named Erivedge as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.8M
- Providers
- 4,955
- Transactions
- 16,251
- Average per transaction
- $110
The per-transaction average — $110 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,955 providers the average total is $361, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $1,782,781 | 99.5% |
| Genentech, Inc. | $8,310 | 0.5% |